Home › Psoriatic Arthritis › Texas › Arlington
Psoriatic Arthritis clinical trials in Arlington, TX
4 studies for Psoriatic Arthritis are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
RecruitingPhase 2
- Precision Comprehensive Research, Colleyville · 10 mi away
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
RecruitingPhase 3
- Clinical Site, Colleyville · 10 mi away
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
RecruitingPhase 1
- Pa0019 136, Colleyville · 10 mi away
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
RecruitingPhase 3
- Heritage Rheumatology and Arthritis Care, Colleyville · 10 mi away
About Psoriatic Arthritis
Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. Find out about symptoms and treatment.
More about Psoriatic Arthritis on MedlinePlus
Psoriatic Arthritis trials in other cities
- Houston, TX8 studies
- Charlotte, NC7 studies
- Tampa, FL6 studies
- Parma, OH6 studies
- Philadelphia, PA6 studies
- Altoona, PA6 studies
- Clearwater, FL5 studies
- Cleveland, OH5 studies
- Plantation, FL5 studies
- New York City, NY5 studies
- Milwaukee, WI5 studies
- San Diego, CA5 studies
Other studies in Arlington
- Steatotic Liver Disease6 studies
- Crohn's Disease5 studies
- Lupus4 studies
- Chronic Kidney Disease4 studies
- Atopic Dermatitis (Eczema)4 studies
- Non-Small Cell Lung Cancer4 studies
- Sjogren's Syndrome4 studies
- Ulcerative Colitis4 studies
- Rheumatoid Arthritis4 studies
- High Blood Pressure3 studies
- Overactive Bladder3 studies
- Breast Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.